Zydus Lifesciences announced the launch of Anyra, India's first indigenously developed biosimilar of Aflibercept 2 mg, aimed at treating a range of serious retinal disorders.

Zydus Lifesciences launches Anyra, India’s first indigenous biosimilar of Aflibercept, aiming to enhance affordable access to advanced diabetic eye-care treatments and strengthen the country’s ...

Learn about central retinal vein occlusion (CRVO), its causes, symptoms, diagnosis, and treatment options for vision loss.

Get a closer look at the biotech ophthalmology landscape to discover exactly how companies are approaching the treatment of eye diseases.

Natasha, a Charlotte graduate student whose vision limitations made doctors say she would never drive, is now driving.

People with worsening cardiovascular-kidney-metabolic syndrome may face an increased risk for developing age-related macular ...

Humans develop sharp vision during early fetal development thanks to an interplay between a vitamin A derivative and thyroid hormones in the retina, Johns Hopkins University scientists have found. The ...

How does our DNA store the massive amount of information needed to build a human being? And what happens when it's stored incorrectly? Jesse Dixon, MD, Ph.D., has spent years studying the way this ...

The offering is expected to close on February 18, 2026, subject to the satisfaction of customary closing conditions. Sidley Austin LLP served as counsel to Opus Genetics in connection with the ...

Zydus Lifesciences is in focus after receiving USFDA clearance with zero observations for its Ahmedabad facility and ...

Cornerstone Eye Associates has become the first practice in Rochester to offer Valeda Light Therapy for the treatment of dry ...